CytoMed Therapeutics Ltd
GDTC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.87M
Close$
$-0.21
123.5% downside
Current Fair Value
123.5% downsideOvervalued by 123.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $10.87 Million |
|---|---|
| Enterprise Value | $9.98 Million |
| Earnings per Share | $-0.34 |
| Beta | 0.05 |
| Outstanding Shares | 11,880,430 |
Return
| Return on Equity | -97.38% |
|---|---|
| Return on Assets | -69.03% |
| Return on Invested Capital | -95.79% |
Valuation & Multiples
| P/E Ratio | -2.68 |
|---|---|
| PEG | -2.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 20.19 |
| Enterprise Value to EBIT | -1.8 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$129,717
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.